# Incidence (epidemiology)

Last updated

In epidemiology, incidence is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during some time period, it is better expressed as a proportion or a rate [1] with a denominator.

## Incidence proportion

Incidence proportion (IP), also known as cumulative incidence, is defined as the probability that a particular event, such as occurrence of a particular disease, has occurred before a given time. [2]

It is calculated dividing the number of new cases during a given period by the number of subjects at risk in the population initially at risk at the beginning of the study. Where the period of time considered is an entire lifetime, the incidence proportion is called lifetime risk. [3]

For example, if a population initially contains 1,000 persons and 28 develop a condition since the disease first occurred until a certain point in time, the cumulative incidence proportion is 28 cases per 1,000 persons, i.e. 2.8%.

IP is related to incidence rate (IR) and duration of exposure (D) as follows: [4]

${\displaystyle IP(t)=1-e^{-IR(t)\cdot D}\,.}$

## Incidence rate

The incidence rate is a measure of the frequency with which a disease or other incident occurs over a specified time period. [5] [6] It is also known as the incidence density rate or person-time incidence rate, [7] when the denominator is the combined person-time of the population at risk (the sum of the time duration of exposure across all persons exposed). [8]

In the same example as above, the incidence rate is 14 cases per 1000 person-years, because the incidence proportion (28 per 1,000) is divided by the number of years (two). Using person-time rather than just time handles situations where the amount of observation time differs between people, or when the population at risk varies with time. [9]

Use of this measure implies the assumption that the incidence rate is constant over different periods of time, such that for an incidence rate of 14 per 1000 persons-years, 14 cases would be expected for 1000 persons observed for 1 year or 50 persons observed for 20 years. [10] When this assumption is substantially violated, such as in describing survival after diagnosis of metastatic cancer, it may be more useful to present incidence data in a plot of cumulative incidence, over time, taking into account loss to follow-up, using a Kaplan-Meier Plot.

## Incidence vs. prevalence

Incidence should not be confused with prevalence, which is the proportion of cases in the population at a given time rather than rate of occurrence of new cases. Thus, incidence conveys information about the risk of contracting the disease, whereas prevalence indicates how widespread the disease is. Prevalence is the proportion of the total number of cases to the total population and is more a measure of the burden of the disease on society with no regard to time at risk or when subjects may have been exposed to a possible risk factor. Prevalence can also be measured with respect to a specific subgroup of a population (see: denominator data). Incidence is usually more useful than prevalence in understanding the disease etiology: for example, if the incidence rate of a disease in a population increases, then there is a risk factor that promotes the incidence.

For example, consider a disease that takes a long time to cure and was widespread in 2002 but dissipated in 2003. This disease will have both high incidence and high prevalence in 2002, but in 2003 it will have a low incidence yet will continue to have a high prevalence (because it takes a long time to cure, so the fraction of individuals that are affected remains high). In contrast, a disease that has a short duration may have a low prevalence and a high incidence. When the incidence is approximately constant for the duration of the disease, prevalence is approximately the product of disease incidence and average disease duration, so prevalence = incidence × duration. The importance of this equation is in the relation between prevalence and incidence; for example, when the incidence increases, then the prevalence must also increase. Note that this relation does not hold for age-specific prevalence and incidence, where the relation becomes more complicated. [11]

### Example

Consider the following example. Say you are looking at a sample population of 225 people, and want to determine the incidence rate of developing HIV over a 10-year period:

• At the beginning of the study (t=0) you find 25 cases of existing HIV. These people are not counted as they cannot develop HIV a second time.
• A follow-up at 5 years (t=5 years) finds 20 new cases of HIV.
• A second follow-up at the end of the study (t=10 years) finds 30 new cases.

If you were to measure prevalence you would simply take the total number of cases (25 + 20 + 30 = 75) and divide by your sample population (225). So prevalence would be 75/225 = 0.33 or 33% (by the end of the study). This tells you how widespread HIV is in your sample population, but little about the actual risk of developing HIV for any person over a coming year.

To measure incidence you must take into account how many years each person contributed to the study, and when they developed HIV. When it is not known exactly when a person develops the disease in question, epidemiologists frequently use the actuarial method, and assume it was developed at a half-way point between follow-ups.[ citation needed ] In this calculation:

• At 5 yrs you found 20 new cases, so you assume they developed HIV at 2.5 years, thus contributing (20 * 2.5) = 50 person-years of disease-free life.
• At 10 years you found 30 new cases. These people did not have HIV at 5 years, but did at 10, so you assume they were infected at 7.5 years, thus contributing (30 * 7.5) = 225 person-years of disease-free life. That is a total of (225 + 50) = 275 person years so far.
• You also want to account for the 150 people who never had or developed HIV over the 10-year period, (150 * 10) contributing 1500 person-years of disease-free life.

That is a total of (1500 + 275) = 1775 person-years of life. Now take the 50 new cases of HIV, and divide by 1775 to get 0.028, or 28 cases of HIV per 1000 population, per year. In other words, if you were to follow 1000 people for one year, you would see 28 new cases of HIV. This is a much more accurate measure of risk than prevalence.

## Related Research Articles

Epidemiology is the study and analysis of the distribution, patterns and determinants of health and disease conditions in defined populations.

In epidemiology, prevalence is the proportion of a particular population found to be affected by a medical condition at a specific time. It is derived by comparing the number of people found to have the condition with the total number of people studied, and is usually expressed as a fraction, a percentage, or the number of cases per 10,000 or 100,000 people.

Mortality rate, or death rate, is a measure of the number of deaths in a particular population, scaled to the size of that population, per unit of time. Mortality rate is typically expressed in units of deaths per 1,000 individuals per year; thus, a mortality rate of 9.5 in a population of 1,000 would mean 9.5 deaths per year in that entire population, or 0.95% out of the total. It is distinct from "morbidity", which is either the prevalence or incidence of a disease, and also from the incidence rate.

The science of epidemiology has matured significantly from the times of Hippocrates, Semmelweis and John Snow. The techniques for gathering and analyzing epidemiological data vary depending on the type of disease being monitored but each study will have overarching similarities.

HIV/AIDS, or human immunodeficiency virus, is considered by some authors a global pandemic. However, the WHO currently uses the term 'global epidemic' to describe HIV. As of 2018, approximately 37.9 million people are infected with HIV globally. There were about 770,000 deaths from AIDS in 2018. The 2015 Global Burden of Disease Study, in a report published in The Lancet, estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year, but remained stable from 2005 to 2015.

In epidemiology, a case fatality rate (CFR) – sometimes called case fatality risk or case-fatality ratio – is the proportion of deaths from a certain disease compared to the total number of people diagnosed with the disease for a particular period. A CFR is conventionally expressed as a percentage and represents a measure of disease severity. CFRs are most often used for diseases with discrete, limited-time courses, such as outbreaks of acute infections. A CFR can only be considered final when all the cases have been resolved. The preliminary CFR, for example, during an outbreak with a high daily increase and long resolution time would be substantially lower than the final CFR.

The epidemiology of autism is the study of the incidence and distribution of autism spectrum disorders (ASD). A 2012 review of global prevalence estimates of autism spectrum disorders found a median of 62 cases per 10,000 people. However there is a lack of evidence from low- and middle-income countries.

In Western Europe, the routes of transmission of HIV are diverse, including paid sex, sex between men, intravenous drugs, mother to child transmission and heterosexual sex. However, many new infections in this region occur through contact with HIV-infected individuals from other regions. In some areas of Europe, such as the Baltic countries, the most common route of HIV transmission is through injecting drug use and heterosexual sex, including paid sex.

HIV is recognized as a health concern in Pakistan with the number of cases growing. Moderately high drug use and lack of acceptance that non-marital sex is common in the society have allowed the HIV epidemic to take hold in Pakistan, mainly among injecting drug users (IDU), male, female and transvestite sex workers as well as the repatriated migrant workers. HIV infection can lead to AIDS that may become a major health issue.

Economic epidemiology is a field at the intersection of epidemiology and economics. Its premise is to incorporate incentives for healthy behavior and their attendant behavioral responses into an epidemiological context to better understand how diseases are transmitted. This framework should help improve policy responses to epidemic diseases by giving policymakers and health-care providers clear tools for thinking about how certain actions can influence the spread of disease transmission.

Since HIV/AIDS was first reported in Thailand in 1984, 1,115,415 adults had been infected as of 2008, with 585,830 having died since 1984. 532,522 Thais were living with HIV/AIDS in 2008. In 2009 the adult prevalence of HIV was 1.3%. As of 2016, Thailand had the highest prevalence of HIV in Southeast Asia at 1.1 percent, the 40th highest prevalence of 109 nations.

HIV/AIDS was first detected in Canada in 1982. In 2018, there were approximately 62,050 people living with HIV/AIDS in Canada. It was estimated that 8,300 people were living with undiagnosed HIV in 2018. Mortality has decreased due to medical advances against HIV/AIDS, especially highly active antiretroviral therapy (HAART).

Epidemiology of periodontal disease is the study of patterns, causes, and effects of periodontal diseases. Periodontal disease is a disease affecting the tissue surrounding the teeth. This causes the gums and the teeth to separate making spaces that become infected. The immune system tries to fight the toxins breaking down the bone and tissue connecting to the teeth to the gums. The teeth will have to be removed. This is an advance stage of gum disease that has multiple definitions. Adult periodontitis affects less than 10 to 15% of the population in industrialized countries, mainly adults around the ages of 50 to 60. The disease is now declining world-wide.

In epidemiology, data or facts about a population is called denominator data. Denominator data are independent of any specific disease or condition. This name is given because in mathematical models of disease, disease-specific data such as the incidence of disease in a population, the susceptibility of the population to a specific condition, the disease resistance, etc. disease-specific variables are expressed as their proportion of some attribute of the general population, and hence appear as the numerator of the fraction or percentage being calculated, general data about the population typically appearing in the denominator; hence the term "denominator data."

Population impact measures (PIMs) are biostatistical measures of risk and benefit used in epidemiological and public health research. They are used to describe the impact of health risks and benefits in a population, to inform health policy.

Malawi ranks 170th out of 174 in the World Health Organization lifespan tables; 88% of the population live on less than £2.40 per day; and 50% are below the poverty line.

Pneumonia is a common respiratory infection, affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 1.4 million deaths in 2010 and 3.0 million deaths in 2016.

The discipline of forensic epidemiology (FE) is a hybrid of principles and practices common to both forensic medicine and epidemiology. FE is directed at filling the gap between clinical judgment and epidemiologic data for determinations of causality in civil lawsuits and criminal prosecution and defense.

An infection rate is the probability or risk of an infection in a population. It is used to measure the frequency of occurrence of new instances of infection within a population during a specific time period.

## References

1. "INCIDENCE - Epidemiology". Encyclopaedia Britannica. Retrieved 3 April 2020.
2. Dodge, Y. (2003). . OUP. ISBN   0-19-920613-9.
3. Rychetnik L, Hawe P, Waters E, Barratt A, Frommer M (July 2004). "A glossary for evidence based public health". J Epidemiol Community Health. 58 (7): 538–45. doi:10.1136/jech.2003.011585. PMC  . PMID   15194712.
4. Bouyer, Jean; Hémon, Denis; Cordier, Sylvaine; Derriennic, Francis; Stücker, Isabelle; Stengel, Bénédicte; Clavel, Jacqueline (2009). Épidemiologie principes et méthodes quantitatives. Paris: Lavoisier.
5. Hargrave, Marshall. "What Does the Incidence Rate Measure?". Investopedia. Retrieved 2019-09-30.
6. Monson, Richard R. (1990-04-25). Occupational Epidemiology, Second Edition. CRC Press. p. 27. ISBN   978-0-8493-4927-0.
7. Last, John M., ed. (2001). A Dictionary of Epidemiology (4 ed.). New York, NY: Oxford University Press. ISBN   978-0-19-514169-6.
8. "Principles of Epidemiology - Lesson 3 - Section 2". Centers for Disease Control and Prevention. 2012-05-18. Retrieved 2021-01-13.
9. Coggon D, Rose G, Barker DJ (1997). "Quantifying diseases in populations". Epidemiology for the Uninitiated (4th ed.). BMJ. ISBN   978-0-7279-1102-5.
10. Dunn, Olive Jean; Clark, Virginia A. (2009). Basic statistics: a primer for the biomedical sciences (4th ed.). Hoboken, N.J.: John Wiley & Sons. pp. 3–5. ISBN   9780470496855 . Retrieved 9 May 2016.
11. Brinks R (2011) "A new method for deriving incidence rates from prevalence data and its application to dementia in Germany", arXiv : 1112.2720